Jose Torregrosa-Diaz

Affiliations

Service d'Oncologie Hématologique et Thérapie Cellulaire, CHU Poitiers, Poitiers, France.
INSERM CIC 1402, CHU Poitiers, Poitiers, France.

Réseau de co-auteurs

Emilie Cayssials 1 collaboration

Pilar Gallego-Hernanz 1 collaboration

Florence Tartarin 1 collaboration

Thomas Systchenko 1 collaboration

Natacha Maillard 1 collaboration

Déborah Desmier 1 collaboration

Antoine Machet 1 collaboration

Emmanuel Fleck 1 collaboration

Anne Corby 1 collaboration

Carine Motard 1 collaboration

Guillaume Denis 1 collaboration

André Herbelin 1 collaboration

Jean-Marc Gombert 1 collaboration

Lydia Roy 1 collaboration

Stéphanie Ragot 1 collaboration

Xavier Leleu 1 collaboration

François Guilhot 1 collaboration

Jean-Claude Chomel 1 collaboration

Pierre Peterlin 1 collaboration

Yannick Le Bris 1 collaboration

Pascal Turlure 1 collaboration

Patrice Chevallier 1 collaboration

Audrey Ménard 1 collaboration

Marie-Pierre Gourin 1 collaboration

Pierre-Yves Dumas 1 collaboration

Sylvain Thepot 1 collaboration

Ana Berceanu 1 collaboration

Sophie Park 1 collaboration

Marie-Anne Hospital 1 collaboration

Thomas Cluzeau 1 collaboration

Simon Bouzy 1 collaboration

Jose-Miguel Torregrosa-Diaz 1 collaboration

Louis Drevon 1 collaboration

Rosa Sapena 1 collaboration

Fatiha Chermat 1 collaboration

Lionel Ades 1 collaboration

Sophie Dimicoli-Salazar 1 collaboration

Sylvie Chevret 1 collaboration

Marie-Christine Béné 1 collaboration

Pierre Fenaux 1 collaboration

Jose Torregrosa-Diaz

Affiliations

Publications (2)

Low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study.

CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study.

Réseau de co-auteurs